HISTAFED COMPOUND LINCTUS

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Kupi sada

Preuzimanje Uputa o lijeku (PIL)
22-05-2017

Aktivni sastojci:

CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLRIDE

Dostupno od:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

ATC koda:

R06AX07

Farmaceutski oblik:

SYRUP

Sastav:

CODEINE PHOSPHATE 5 MG / 5 ML; PSEUDOEPHEDRINE HYDROCHLORIDE 30 MG / 5 ML; TRIPROLIDINE HYDROCHLRIDE 1.25 MG / 5 ML

Administracija rute:

PER OS

Tip recepta:

Required

Proizveden od:

TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL

Terapijska grupa:

TRIPROLIDINE

Područje terapije:

TRIPROLIDINE

Terapijske indikacije:

Antitussive syrup for the symptomatic relief of cough accompanied by nasal congestion and congestion of the upper respiratory tract.

Datum autorizacije:

2022-09-30

Uputa o lijeku

                                107378010
0317F
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986
The medicine is dispensed with a doctor’s prescription only
HISTAFED COMPOUND LINCTUS
SYRUP
Each 5 ml contains:
Triprolidine HCl
1.25 mg
Pseudoephedrine hydrochloride 30 mg
Codeine phosphate
5 mg
For inactive ingredients in the preparation – see section 6
“Further
Information”.
READ THIS LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICINE.
This
leaflet contains concise information about the medicine. If you have
further
questions, refer to the doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may
harm them, even if it seems to you that their medical condition is
similar.
The medicine is not intended for children under the age of 12.
The medicine is not recommended for children and adolescents aged
12-18
suffering from respiratory problems.
The medicine is not intended for those who are known to produce
significant
quantities of morphine following a dose of codeine (they belong to the
group
of “CYP2D6 ultra-rapid metabolizers”), since they are at increased
risk of
suffering from severe side effects as a result of taking codeine.
1. WHAT IS THE MEDICINE INTENDED FOR?
Antitussive when accompanied with nasal and upper respiratory tract
congestion.
THERAPEUTIC GROUP:
Triprolidine is an H1 antihistamine.
Pseudoephedrine is an alpha agonist.
Codeine Phosphate is an opiate cough suppressant.
2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF:
∙ You are sensitive to the active ingredients or to other members of
the
opiate family or to any of the additional ingredients contained in the
medicine (see section 6).
∙ Do not use in children under the age of 12.
∙ The medicine is not intended for those who are known to produce
significant quantities of morphine following a dose of codeine (they
belong
to the group of “CYP2D6 ultra-rapid metabolizers”), since they are
at
increased risk of suffering from severe side effects as a result of
ta
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku arapski 22-05-2017
Uputa o lijeku Uputa o lijeku hebrejski 22-05-2017